Unknown

Dataset Information

0

HLSC-Derived Extracellular Vesicles Attenuate Liver Fibrosis and Inflammation in a Murine Model of Non-alcoholic Steatohepatitis.


ABSTRACT: Extracellular vesicles (EVs) are membrane vesicles released virtually by all cell types. Several studies have shown that stem cell-derived EVs may mimic both in vitro and in vivo the biological effects of the cells. We recently demonstrated that non-alcoholic steatohepatitis (NASH) is inhibited by treatment with human liver stem cells (HLSCs). The aim of the present study was to evaluate whether EVs released by HLSCs influence the progression of NASH, induced by a diet deprived of methionine and choline, in immunocompromised mice. EV treatment was initiated after 2 weeks of diet with a biweekly administration of three different doses. Bio-distribution evaluated by optical imaging showed a preferential accumulation in normal and, in particular, in fibrotic liver. EV treatment significantly improved liver function and reduced signs of liver fibrosis and inflammation at both morphological and molecular levels. In particular, we observed that, out of 29 fibrosis-associated genes upregulated in NASH liver, 28 were significantly downregulated by EV treatment. In conclusion, HLSC-derived EVs display anti-fibrotic and anti-inflammatory effects in a model of chronic liver disease, leading to an improvement of liver function.

SUBMITTER: Bruno S 

PROVIDER: S-EPMC7001005 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

HLSC-Derived Extracellular Vesicles Attenuate Liver Fibrosis and Inflammation in a Murine Model of Non-alcoholic Steatohepatitis.

Bruno Stefania S   Pasquino Chiara C   Herrera Sanchez Maria Beatriz MB   Tapparo Marta M   Figliolini Federico F   Grange Cristina C   Chiabotto Giulia G   Cedrino Massimo M   Deregibus Maria Chiara MC   Tetta Ciro C   Camussi Giovanni G  

Molecular therapy : the journal of the American Society of Gene Therapy 20191028 2


Extracellular vesicles (EVs) are membrane vesicles released virtually by all cell types. Several studies have shown that stem cell-derived EVs may mimic both in vitro and in vivo the biological effects of the cells. We recently demonstrated that non-alcoholic steatohepatitis (NASH) is inhibited by treatment with human liver stem cells (HLSCs). The aim of the present study was to evaluate whether EVs released by HLSCs influence the progression of NASH, induced by a diet deprived of methionine and  ...[more]

Similar Datasets

| S-EPMC5483390 | biostudies-literature
| S-EPMC9477333 | biostudies-literature
| S-EPMC10655353 | biostudies-literature
| S-EPMC8512699 | biostudies-literature
| S-EPMC7666601 | biostudies-literature
| S-EPMC8425476 | biostudies-literature
| S-EPMC9101015 | biostudies-literature
| S-EPMC9327366 | biostudies-literature
| S-EPMC6589210 | biostudies-literature
| S-EPMC7789736 | biostudies-literature